-

Wolters Kluwer Survey Finds Broad Presence of Unsanctioned AI Tools in Hospitals and Health Systems

Findings highlight need for clear governance and compliance policies to target “shadow AI” tools and applications

WALTHAM, Mass.--(BUSINESS WIRE)--A new survey from Wolters Kluwer Health of healthcare professionals and administrators reveals a growing trend: unauthorized AI tools and apps, known as “shadow AI,” are currently being used across hospitals and health systems in the U.S., including for direct patient care. This could raise concerns about patient safety, data privacy, and regulatory compliance. According to the survey, 40% of respondents have encountered an unauthorized AI tool in their organizations, and nearly 20% have used them.

“Doctors and administrators are choosing AI tools for speed and workflow optimization, and when approved options aren’t available, they may be taking risks,” said Yaw Fellin, Senior Vice President and General Manager, Clinical Decision Support and Provider Solutions, Wolters Kluwer Health. “Shadow AI isn’t just a technical issue; it’s a governance issue that may raise patient safety concerns. Leaders must act now to close the policy gap around AI use, develop clear compliance guidelines, and ensure that only validated, secure, enterprise-ready AI tools are used in clinical care.”

Key healthcare shadow AI survey findings:

  • Shadow AI is widespread in health systems: Forty percent of healthcare professionals have encountered unauthorized AI tools in the workplace, and nearly 20 percent admit to using them. The top reasons? Half of respondents point to a need for faster workflows. For providers, curiosity and experimentation ranked slightly higher than “better functionality.” One in 10 said they had used an unauthorized AI tool for a direct patient care use case.
  • Gaps in policy development and awareness: Administrators are three times more likely to be actively involved in healthcare AI policy development than providers (30% vs. 9%), suggesting policy ownership is more centralized within hospital administrative roles. When it comes to awareness however, 29 percent of providers are aware of the main policies versus 17 percent of administrators.
  • A majority of healthcare professionals use AI tools and believe AI will have a positive impact on healthcare: More than half of healthcare professionals frequently use AI tools or rely on AI tools for their work. Healthcare professionals express strong optimism about AI’s impact on healthcare, with nearly 90 percent agreeing or strongly agreeing that AI will significantly improve healthcare within the next five years. The top use for AI for both providers (60%) and administrators (78%) was data analysis indicating deep integration into workflow.
  • Patient safety is a top concern: Both providers (25%) and administrators (26%) rank patient safety as their top concern around AI in healthcare. Among administrators, patient safety is the top overall concern, followed by concerns about privacy and data breaches. Providers rank inaccurate outputs as their second biggest concern, with administrators ranking privacy second.
  • Health data security is also a worry: Nearly a quarter (23%) of healthcare professionals express concern about privacy and security risks associated with AI in healthcare, highlighting fears of healthcare data breaches, unauthorized access, and the need for robust protection measures.

The shadow AI survey findings echoed the perspective of Scott Simeone, SVP and Chief Information Officer at Tufts Medicine:

“GenAI is showing high potential for creating value in healthcare but scaling it depends less on the technology and more on the maturity of organizational governance. While progress has been made in governance, there is still work to be done to evolve tools for control and monitoring, so they scale for clinical contexts. As clinical use grows, health systems need enterprise‑grade controls, transparency, and literacy—so clinicians and patients understand when AI is supporting decisions, how it works, and where human judgment remains essential.”

See more information on the Wolters Kluwer healthcare shadow AI survey.

Survey conducted online by CITE Research, Inc. for Wolters Kluwer Health, December 2025, to 518 healthcare professionals evenly divided between providers and administrators.

About Wolters Kluwer

Wolters Kluwer (EURONEXT: WKL) is a global leader in information, software, and services for professionals in Health, Tax & Accounting, Financial Corporate Compliance, Legal & Regulatory, and Corporate Performance & ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2024 annual revenues of €5.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,400 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.

Contacts

Media Contact
Suzanne Moran
Associate Director, External Communications
Wolters Kluwer Health
+1 781-255-5843
suzanne.moran@wolterskluwer.com

Wolters Kluwer Health

AEX:WKL

Release Versions

Contacts

Media Contact
Suzanne Moran
Associate Director, External Communications
Wolters Kluwer Health
+1 781-255-5843
suzanne.moran@wolterskluwer.com

Social Media Profiles
More News From Wolters Kluwer Health

Barking, Havering and Redbridge University Hospitals NHS Trust selects Wolters Kluwer’s UpToDate Enterprise Edition to advance clinical decision-making and patient care

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT), an acute care provider serving East London and Essex, has adopted UpToDate® Enterprise Edition. The market-leading clinical decision support (CDS) system will help healthcare administrators and clinicians deliver consistently high-quality care across the Trust which is recognized as a center of excellence in neuroscience, stroke care, and maternity...

Wolters Kluwer Adds UpToDate Lexidrug’s Comprehensive Drug Information to GenAI-powered Clinical Decision Support, UpToDate Expert AI

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced the first in a series of planned expansions of its GenAI clinical decision support solution, UpToDate® Expert AI. Comprehensive medication information from UpToDate Lexidrug, the drug reference tool trusted by thousands of clinicians, pharmacists and hospital pharmacies, will now be integrated into the AI resource for enhanced medication and therapeutic decision support. “Since we launched UpToDate Expert AI in September, we...

HLTH 2025: Wolters Kluwer showcases UpToDate Expert AI and workflow innovations

WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health will showcase the future of clinical decision support with Expert AI at HLTH 2025, booth #3218, where attendees can see demonstrations of the recently launched UpToDate Expert AI. Designed to empower healthcare organizations with responsible, evidence-based AI, UpToDate Expert AI streamlines clinical workflows and accelerates informed decision-making through clinical intelligence. Wolters Kluwer Health will also present innovative solutions...
Back to Newsroom